260 related articles for article (PubMed ID: 32555589)
1. Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.
Rambach G; Fleischer V; Harpf V; Lackner M; Meinitzer A; Maier H; Engesser J; Lass-Flörl C; Speth C
PLoS One; 2020; 15(6):e0234063. PubMed ID: 32555589
[TBL] [Abstract][Full Text] [Related]
2. Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.
Schulze B; Rambach G; Schwartze VU; Voigt K; Schubert K; Speth C; Jacobsen ID
Virulence; 2017 Nov; 8(8):1657-1667. PubMed ID: 28750194
[TBL] [Abstract][Full Text] [Related]
3. Hyphae of
Samdavid Thanapaul RJR; Roberds A; Rios KE; Walsh TJ; Bobrov AG
J Fungi (Basel); 2023 Sep; 9(10):. PubMed ID: 37888214
[No Abstract] [Full Text] [Related]
4. Complement, but Not Platelets, Plays a Pivotal Role in the Outcome of Mucormycosis In Vivo.
Harpf V; Rambach G; Parth N; Neurauter M; Fleischer V; Lackner M; Lass-Flörl C; Würzner R; Speth C
J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836277
[TBL] [Abstract][Full Text] [Related]
5. Impairment of Th cell response in Card9 knockout mice with cutaneous mucormycosis caused by Rhizopus arrhizus.
Sun L; Wan Z; Li R; Yu J
Exp Dermatol; 2019 Nov; 28(11):1244-1251. PubMed ID: 31407820
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
[TBL] [Abstract][Full Text] [Related]
7. Stress response in medically important Mucorales.
Singh P; Paul S; Shivaprakash MR; Chakrabarti A; Ghosh AK
Mycoses; 2016 Oct; 59(10):628-35. PubMed ID: 27292160
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids alter alveolar macrophage control of Lichtheimia corymbifera spores in an ex vivo mouse model.
Brunet K; Arrivé F; Martellosio JP; Lamarche I; Marchand S; Rammaert B
Med Mycol; 2021 Jul; 59(7):694-700. PubMed ID: 33369666
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EGFR Signaling Protects from Mucormycosis.
Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM
mBio; 2018 Aug; 9(4):. PubMed ID: 30108171
[TBL] [Abstract][Full Text] [Related]
10. In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Schwarz P; Schwarz PV; Felske-Zech H; Dannaoui E
J Antimicrob Chemother; 2019 Jul; 74(7):1921-1927. PubMed ID: 30934052
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
Gebremariam T; Alkhazraji S; Lin L; Wiederhold NP; Garvey EP; Hoekstra WJ; Schotzinger RJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652241
[TBL] [Abstract][Full Text] [Related]
12. VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
Gebremariam T; Wiederhold NP; Fothergill AW; Garvey EP; Hoekstra WJ; Schotzinger RJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7815-7. PubMed ID: 26369977
[TBL] [Abstract][Full Text] [Related]
13. Sterol Composition of Clinically Relevant Mucorales and Changes Resulting from Posaconazole Treatment.
Müller C; Neugebauer T; Zill P; Lass-Flörl C; Bracher F; Binder U
Molecules; 2018 May; 23(5):. PubMed ID: 29783739
[TBL] [Abstract][Full Text] [Related]
14. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714
[TBL] [Abstract][Full Text] [Related]
16. Rapid screening for human-pathogenic Mucorales using rolling circle amplification.
Dolatabadi S; Najafzadeh MJ; de Hoog GS
Mycoses; 2014 Dec; 57 Suppl 3():67-72. PubMed ID: 25187214
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mitogenomes from four Mucorales species and insights into pathogenicity.
Liang G; Zhang M; Xu W; Wang X; Zheng H; Mei H; Liu W
Mycoses; 2022 Jan; 65(1):45-56. PubMed ID: 34570921
[TBL] [Abstract][Full Text] [Related]
19. The comparative virulence of thermotolerant Mucorales species in mice.
Kitz DJ; Embree RW; Cazin J
Mycopathologia; 1983 Apr; 82(1):17-22. PubMed ID: 6877338
[TBL] [Abstract][Full Text] [Related]
20. Lichtheimia corymbifera Colonization Leading to Pulmonary Infection Can Be Prevented with Liposomal Amphotericin B in a New Murine Model.
Brunet T; Brunet K; Jouvion G; Cateau E; Marchand S; Rammaert B
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
